1. Home
  2. RAIL vs KZIA Comparison

RAIL vs KZIA Comparison

Compare RAIL & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FreightCar America Inc.

RAIL

FreightCar America Inc.

SELL

Current Price

$4.27

Market Cap

141.0M

Sector

Industrials

ML Signal

SELL

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

HOLD

Current Price

$4.87

Market Cap

76.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAIL
KZIA
Founded
1901
1994
Country
United States
Australia
Employees
N/A
10
Industry
Railroads
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.0M
76.5M
IPO Year
2005
2002

Fundamental Metrics

Financial Performance
Metric
RAIL
KZIA
Price
$4.27
$4.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$10.67
★ $27.60
AVG Volume (30 Days)
★ 284.1K
251.4K
Earning Date
11-09-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 134.94
N/A
EPS
★ 0.32
N/A
Revenue
★ $500,991,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$48.30
N/A
P/E Ratio
$14.31
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.85
$4.86
52 Week High
$14.90
$17.40

Technical Indicators

Market Signals
Indicator
RAIL
KZIA
Relative Strength Index (RSI) 38.73 23.06
Support Level $3.94 N/A
Resistance Level $5.48 $14.85
Average True Range (ATR) 0.35 0.69
MACD 0.07 -0.20
Stochastic Oscillator 21.99 4.69

Price Performance

Historical Comparison
RAIL
KZIA

About RAIL FreightCar America Inc.

FreightCar America Inc is a diversified manufacturer and supplier of railcars and railcar components. It designs and manufactures a variety of railcar types for transportation of bulk commodities and containerized freight products in North America. The company also provides railcar rebody and repair services, railcar conversion services, and supplies railcar parts. The company has two segments: Manufacturing and Aftermarket. The majority of the company's revenue is derived from the Manufacturing segment, which includes new railcar manufacturing, used railcar sales, and various conversions and rebodies. Geographically, it generates the maximum revenue from the United States.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is engaged in pharmaceutical drug development. The company is an emerging oncology-focused biotechnology company that has a portfolio of development candidates, diversified across several distinct technologies, with the potential to yield first-in-class and best-in-class agents in a range of oncology indications. The company operates in one business segment, the research and development of pharmaceutical products in the field of oncology.

Share on Social Networks: